The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

Keyphrases

• Liver Transplant Recipients 100%
• Tacrolimus 100%
• Kidney Transplant Recipients 100%
• Antiretroviral Agents 100%
• Highly Active 90%
• Nelfinavir 40%
• Protease Inhibitors 40%
• Indinavir 30%
• Nucleoside Reverse Transcriptase Inhibitors 30%
• Liver Transplantation 20%
• Immunosuppression 20%
• Mean Dose 20%
• Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) 20%
• Trough Concentration 20%
• Therapy Regimen 20%
• Kidney Transplantation 10%
• Viral 10%
• HIV-positive 10%
• Clinical Response 10%
• Metabolism 10%
• Antiretroviral Therapy 10%
• HIV Patients 10%
• Protease Inhibitor Therapy 10%
• Cyclosporine 10%
• Pretransplant 10%
• Calcineurin Inhibitors 10%
• Immunosuppressive Drugs 10%
• Kidney Transplant 10%
• Drug Interactions 10%
• Solid Organ Transplantation 10%
• Mycophenolate Mofetil 10%
• Organ Transplant 10%
• Cytochrome P450 3A (CYP3A) 10%
• Potential Drug Interactions 10%
• Enzyme Complex 10%
• HIV-positive Recipient 10%
• Drug Level Monitoring 10%
• Tacrolimus Metabolism 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Tacrolimus 100%
• Antiretrovirus Agent 100%
• Proteinase Inhibitor 45%
• HIV 36%
• Nelfinavir 36%
• Indinavir 27%
• RNA Directed DNA Polymerase Inhibitor 27%
• Nonnucleoside Reverse Transcriptase Inhibitor 18%
• Drug Interaction 18%
• Immunosuppressive Agent 9%
• Ciclosporin 9%
• Cytochrome 9%
• Calcineurin Inhibitor 9%
• Mycophenolate Mofetil 9%